genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.100
+0.002 (0.18%)
Oct 13, 2026, 2:38 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 17.66 million as of October 13, 2026. It is the 35,786th most valuable company in the world and the 764th biggest in the United Kingdom. Its market cap has increased by 603.36% in one year.
Market Cap
17.66M
Enterprise Value
17.77M
Revenue
1.17M
Global Rank
Country Rank
#764 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 17.66M, an increase of 51.33%. That is a compound annual growth rate of 2.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 18.46M | 104.95% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.53B |
| GSK plc | 70.96B |
| Haleon | 31.25B |
| Smith & Nephew | 8.73B |
| Provexis | 24.16M |
| RUA Life Sciences | 18.62M |
| IXICO | 17.95M |
| Inspiration Healthcare Group | 16.59M |